S. Ewig (Bochum, Germany), W. Boersma (Oudorp, The Netherlands)
Effects of salmeterol on the ciliary beat in patients with community-acquired pneumonia
G. Piatti, U. Ambrosetti, M. Dal Sasso, P. Braga, C. Gambardella, L. Allegra (Milan, Italy)
|   |
Relationship between clinical outcomes and variations in subspecialty practice in the management of pneumonia
T. K. Lim, B. H. Heng, D. Zhu, H. Y. Tai, J. Cheah (Singapore; Singapore)
| |
Angiotensin-converting enzyme inhibitor prevents aspiration pneumonia by ameliorating swallowing disorder in pharyngeal phase
T. Shimizu, S. Fujioka, H. Otonashi, Y. Fukuda, M. Kondo (Ibaraki, Japan)
| |
Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia
J. Blanquer, M. L. Briones, C. Muñoz, C. Gimeno, D. Blanquer, J. Marin (Valencia, Palma de Mallorca, Spain)
| |
Impact of bacterial colonization in lower respiratory tract on fibrile episode in patietns with lung cancer
R. Gohara, Y. Mizoguchi, M. Ichiki, H. Yoshida, T. Rikimaru, H. Aizawa (Yame, Kurume, Japan)
| |
Relation between the empiric initial therapy of S.pneumoniae community-acquired pneumonia (SP-CAP) and mortality in thirty days of outcome. On behalf of Pneumococcal Pneumonia Cooperative Study Group, Grupo TIR, SEPAR
J. Aspa, O. Rajas, F. Rodriguez de Castro, R. Zalacain, R. De Celis, J. Blanquer, A. Torres (Madrid, Spain)
| |
Effects of empirical antibacterial therapy on the degree of systemic inflammatory response in patients with severe community-acquired pneumonia (SCAP)
A. A. Igonin, V. W. Armstrong, M. Shipkova, N. B. Lazareva, V. G. Kukes, M. Oellerich (Moscow, Russia; Goettingen, Germany)
| |
Appropriateness of CAP guidelines in different age groups
C. Hand, H. Kothe, A. Wulf, J. Rupp, K. Dalhoff (Luebeck, Germany)
| |